TR199800908T2 - 25-hidroksi-16-en-26,27-bishomo-kolekalsiferoller - Google Patents

25-hidroksi-16-en-26,27-bishomo-kolekalsiferoller

Info

Publication number
TR199800908T2
TR199800908T2 TR1998/00908T TR9800908T TR199800908T2 TR 199800908 T2 TR199800908 T2 TR 199800908T2 TR 1998/00908 T TR1998/00908 T TR 1998/00908T TR 9800908 T TR9800908 T TR 9800908T TR 199800908 T2 TR199800908 T2 TR 199800908T2
Authority
TR
Turkey
Prior art keywords
hydroxy
carbon
bishomo
cholecalciferol
ene
Prior art date
Application number
TR1998/00908T
Other languages
English (en)
Inventor
Anthony Iacobelli Jerome
Radoje Uskokovic Milan
Original Assignee
F.Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F.Hoffmann-La Roche Ag filed Critical F.Hoffmann-La Roche Ag
Publication of TR199800908T2 publication Critical patent/TR199800908T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/22—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system
    • C07C35/23—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with hydroxy on a condensed ring system having two rings
    • C07C35/32—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with hydroxy on a condensed ring system having two rings the condensed ring system being a (4.3.0) system, e.g. indenols
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/29—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups
    • C07C45/292—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups with chromium derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/30—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation
    • C07C45/305—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation with halogenochromate reagents, e.g. pyridinium chlorochromate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/385—Saturated compounds containing a keto group being part of a ring
    • C07C49/487—Saturated compounds containing a keto group being part of a ring containing hydroxy groups
    • C07C49/507—Saturated compounds containing a keto group being part of a ring containing hydroxy groups polycyclic
    • C07C49/513—Saturated compounds containing a keto group being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Bulus, formül 1'in bir bilesimi ile ilgilidir, burada A; E ya da Z stereokimyasal yapilandirmaya sahip bir karbon-karbon çift bagdir ya da A bir karbon-karbon üçlü bagdir, Et etildir ve R hidroksidir ve R1 hidrojen ya da =CH2 'dir ya da R hidrojen ya da floro ve R1=CH2 'dir. HL-60 hücre farklilasmasini stimüle ederler ve buna göre lösemi gibi neoplastik hastaliklarin tedavisinde yararli maddelerdir.
TR1998/00908T 1995-11-22 1996-11-13 25-hidroksi-16-en-26,27-bishomo-kolekalsiferoller TR199800908T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US874495P 1995-11-22 1995-11-22

Publications (1)

Publication Number Publication Date
TR199800908T2 true TR199800908T2 (tr) 2001-05-21

Family

ID=21733405

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1998/00908T TR199800908T2 (tr) 1995-11-22 1996-11-13 25-hidroksi-16-en-26,27-bishomo-kolekalsiferoller

Country Status (27)

Country Link
US (1) US6030963A (tr)
EP (1) EP0874814B1 (tr)
JP (2) JP3917184B2 (tr)
KR (1) KR19990071535A (tr)
CN (1) CN1076347C (tr)
AR (1) AR004726A1 (tr)
AT (1) ATE241599T1 (tr)
AU (1) AU705942B2 (tr)
BR (1) BR9611741A (tr)
CA (1) CA2237897C (tr)
CZ (1) CZ293489B6 (tr)
DE (1) DE69628458T2 (tr)
DK (1) DK0874814T3 (tr)
EA (1) EA002772B1 (tr)
ES (1) ES2198501T3 (tr)
HU (1) HUP9903715A3 (tr)
IL (1) IL124290A (tr)
MX (1) MX9803966A (tr)
MY (1) MY116582A (tr)
NO (1) NO982304L (tr)
NZ (1) NZ322035A (tr)
PL (1) PL186845B1 (tr)
PT (1) PT874814E (tr)
TR (1) TR199800908T2 (tr)
TW (1) TW403735B (tr)
WO (1) WO1997019058A1 (tr)
ZA (1) ZA969625B (tr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5939408A (en) * 1996-05-23 1999-08-17 Hoffman-La Roche Inc. Vitamin D3 analogs
GB9625271D0 (en) * 1996-12-04 1997-01-22 Leo Pharm Prod Ltd Chemical compounds
US5919986A (en) * 1997-10-17 1999-07-06 Hoffmann-La Roche Inc. D-homo vitamin D3 derivatives
CH698144B1 (fr) * 2003-09-24 2009-05-29 Bioxell Spa Analogue de la vitamine D3
SG110107A1 (en) * 2003-09-24 2005-04-28 Bioxell Spa Compound and use in treatment
JP2007506780A (ja) * 2003-09-24 2007-03-22 ビオエクセル エスピーエー 膀胱機能障害の治療方法
GB2407499B (en) * 2003-11-03 2008-02-27 Bioxell Spa Vitamin D3 analogue for use in the treatment of BPH
AU2005289664A1 (en) * 2004-09-24 2006-04-06 Bioxell S.P.A. 20-cycloalkyl,26,27-alkyl/haloalkyl vitamin D3 compounds and methods of use thereof
US20100009949A1 (en) * 2006-03-24 2010-01-14 Bioxell S.P.A. Novel method
WO2012118154A1 (ja) * 2011-03-02 2012-09-07 学校法人日本大学 パーシャルアゴニスト活性を持つ新規ビタミンd受容体モジュレーター

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5087619A (en) * 1988-01-20 1992-02-11 Hoffman-La Roche Inc. Vitamin D3 analogs
ZA8923B (en) * 1988-01-20 1989-09-27 Hoffmann La Roche 16-dehydro-vitamin d3-derivatives
US5145846A (en) * 1988-01-20 1992-09-08 Hoffmann-La Roche Inc. Vitamin D3 analogs
TW267161B (tr) * 1992-11-20 1996-01-01 Hoffmann La Roche

Also Published As

Publication number Publication date
DE69628458T2 (de) 2004-03-18
MY116582A (en) 2004-02-28
PL186845B1 (pl) 2004-03-31
AU7570296A (en) 1997-06-11
AR004726A1 (es) 1999-03-10
BR9611741A (pt) 1999-02-23
DE69628458D1 (de) 2003-07-03
DK0874814T3 (da) 2003-09-22
IL124290A (en) 2002-09-12
ES2198501T3 (es) 2004-02-01
EA199800468A1 (ru) 1998-12-24
NZ322035A (en) 1998-11-25
CA2237897C (en) 2006-01-03
CN1076347C (zh) 2001-12-19
JP2000500476A (ja) 2000-01-18
EP0874814B1 (en) 2003-05-28
HUP9903715A2 (hu) 2000-03-28
CZ157298A3 (cs) 1998-09-16
CA2237897A1 (en) 1997-05-29
ZA969625B (en) 1997-05-22
CZ293489B6 (cs) 2004-05-12
HUP9903715A3 (en) 2000-09-28
WO1997019058A1 (en) 1997-05-29
EP0874814A1 (en) 1998-11-04
JP3917184B2 (ja) 2007-05-23
PT874814E (pt) 2003-09-30
US6030963A (en) 2000-02-29
NO982304D0 (no) 1998-05-20
CN1202885A (zh) 1998-12-23
ATE241599T1 (de) 2003-06-15
NO982304L (no) 1998-07-07
TW403735B (en) 2000-09-01
AU705942B2 (en) 1999-06-03
PL326837A1 (en) 1998-10-26
MX9803966A (es) 1998-09-30
KR19990071535A (ko) 1999-09-27
EA002772B1 (ru) 2002-08-29
JP2007126458A (ja) 2007-05-24

Similar Documents

Publication Publication Date Title
TR199701042T1 (tr) Yeni taksoidler, hazirlanislari, ispençiyari kompozisyonlari.
CA1264740C (en) Tetrapyrrole therapeutic agents
ATE202286T1 (de) Rhodamin-derivate für die photodynamische therapie von krebs und in-vitro reinigung von leukämien
ES2155874T3 (es) Composiciones cosmeticas que contienen acido betulinico.
TR200000289T2 (tr) Kimyasal bileşimler
DE69427706D1 (en) Cryptophycine
ATE71947T1 (de) Tetrapyrrol-therapiemittel.
DE3586206D1 (de) Metoprololsuccinat und dieses enthaltende pharmazeutische zusammensetzung.
IL112495A0 (en) Phenylacetic acid derivatives, their preparation and compositions containing them
TR199900239T2 (tr)
BG102425A (en) (methylsulphonyl)phenyl-2-(5h)-furanons as cyclooxygenase-2-inhibitors
EP0695758A3 (en) Human cancer inhibitory pentapeptide amides and esters
DE69623476D1 (de) Herstellung von Zinkbrennstofftabletten
TR199800908T2 (tr) 25-hidroksi-16-en-26,27-bishomo-kolekalsiferoller
UA29466C2 (uk) Фармацевтична композиція з антипухлинною активністю
IT1180156B (it) Composizione cosmetica a base di glicoproteine per il trattamento della pelle
TR200001869T2 (tr) Terapetik Maddeler
TW334434B (en) Novel quinazoline compound and anti-tumor agent
TR199700694T1 (tr) D vitamini türevlerinin dermotolojik kullanimi.
BR9611472A (pt) Compostos de di-terc-butilfenol contendo enxofre úteis como agentes antiinflamatórios
TR200002266T2 (tr) İnterlokin-6 üretimini canlandırıcı etkinliğe sahip bir bileşik içeren kozmetik kompozisyon.
MX9804483A (es) Procedimiento de modificacion in vivo.
TR199900662T2 (tr) 1-Hidroksi-2-piridonlarin seborik dermatit tedavisi amaciyla kullanimi
ES2120667T3 (es) Sal de l-carnitina y composiciones cosmeticas y farmaceuticas que la contienen para tratamiento de dermatosis.
FR2378741A1 (fr) Acides garyl goxo isovaleriques doues de proprietes antiphlogistiques et antalgiques